InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.48
(
0.54%
)
Bitcoin
62,343.59
(
-1.29%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

montanus

Send PM Follow Ignore
Followers 13
Posts 1001
Boards Moderated 0
Alias Born 03/12/2009

montanus

Re: None

Saturday, 03/12/2016 9:19:40 AM

Saturday, March 12, 2016 9:19:40 AM

Post# of 20775
MR. MAZA,

an update regarding the new findings in ponezumab preclinical and clinical trial is a must!
There is a license agreement with PFE and ILNS is a public company.
An interview with an expert, MARK LILLIE ponezumab director @PFE and Daniel Chain would make sense!

https://www.fightaging.org/archives/2016/03/recent-advances-in-anti-amyloid-passive-immunization.php

https://clinicaltrials.gov/ct2/show/NCT01821118?term=ponezumab&rank=5


Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up